H1B Report
Side-by-side comparison

BioStat Solutions, Inc. vs COGNIZANT TECHNOLOGY SOLUTIONS US CORP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
BioStat Solutions, Inc.
MDRank #
Entity B
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
TXRank #2FEIN 13-3924155

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricBioStat Solutions, Inc.COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Total filings33128,852
Certified %72.73%96.13%
Denied %0.00%0.28%
Withdrawn %0.00%2.23%
Cert-withdrawn %27.27%1.36%
Rank#2
Active yearsFY2011–FY2019FY2010–FY2026
Worksite stateMDTX

Outcomes — BioStat Solutions, Inc.

DOL case-status mix.

Outcome breakdown: Certified 72.7%, Cert-withdrawn 27.3%
Outcome breakdown
OutcomeShare
Certified72.7%
Cert-withdrawn27.3%
Certified72.7%
Cert-withdrawn27.3%

Outcomes — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

DOL case-status mix.

Outcome breakdown: Certified 96.1%, Cert-withdrawn 1.4%, Withdrawn 2.2%, Denied 0.3%
Outcome breakdown
OutcomeShare
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%
Certified96.1%
Cert-withdrawn1.4%
Withdrawn2.2%
Denied0.3%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

BioStat Solutions, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20114
FY20125
FY20134
FY20149
FY20153
FY20164
FY20171
FY20182
FY20191
FY20200
FY20210
FY20220
FY20230
FY20240
FY20250
FY20260
COGNIZANT TECHNOLOGY SOLUTIONS US CORP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20101,476
FY20112,735
FY20121,772
FY20131,557
FY20142,189
FY20153,112
FY20164,612
FY20172,384
FY201812,460
FY201925,569
FY20203,117
FY202110,079
FY202213,705
FY202315,729
FY202411,437
FY202511,140
FY20265,779

Top 5 occupations — BioStat Solutions, Inc.

Top 5 occupations — COGNIZANT TECHNOLOGY SOLUTIONS US CORP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.